Semenogelin II (SEMG2) (N-Term) Peptide
Quick Overview for Semenogelin II (SEMG2) (N-Term) Peptide (ABIN8111314)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- SEMG2 Peptide - N-terminal region
-
Sequence
- GQKGQHYFGQ KDQQHTKSKG SFSIQHTYHV DINDHDWTRK SQQYDLNALH
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-SEMG2 Antibody(ARP42092_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- SEMG2 (Semenogelin II (SEMG2))
-
Background
-
Background Information: The secreted protein encoded by this gene is involved in the formation of a gel matrix that encases ejaculated spermatozoa. Proteolysis by the prostate-specific antigen (PSA) breaks down the gel matrix and allows the spermatozoa to move more freely. The encoded protein is found in lesser abundance than a similar semenogelin protein. The genes encoding these two semenogelin proteins are found in a cluster on chromosome 20.
Alternative Symbols: SGII
-
Molecular Weight
- 63kDa
-
Gene ID
- 6407
-
NCBI Accession
- NP_002999
-
UniProt
- Q02383
Target
-